{"id":"imiclopazine","rwe":[],"tags":[{"label":"imiclopazine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"imiclopazin","offLabel":[],"synonyms":["imiclopazine dihydrochloride","imiclopazine hydrochloride","chlorimiphenine","chlorimpiphenin","chlorimpiphenine","imiclopazin","imiclopazine"],"timeline":[],"approvals":[],"brandName":"Imiclopazin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"imiclopazine","explanation":"Imagine your brain is a city with many different neighborhoods. Imiclopazin is like a special key that unlocks a specific door in one of those neighborhoods, allowing it to communicate with other parts of the city in a unique way. This can help to regulate various bodily functions, but the exact details of how it works are still being studied.","oneSentence":"Imiclopazin is thought to work by interacting with a specific target in the brain, although the exact nature of this interaction is not well understood.","technicalDetail":"Imiclopazin is a small molecule that binds to a specific receptor or enzyme, although the precise molecular details of this interaction are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3758","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IMICLOPAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:01:29.757361","biosimilars":[],"competitors":[],"genericName":"imiclopazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"WGL8B3MDAS","CHEBI":"CHEBI:135784","INN_ID":"2369","UMLSCUI":"C0601644","ChEMBL_ID":"CHEMBL2105043","PUBCHEM_CID":"23896","SECONDARY_CAS_RN":"7414-95-1","MESH_SUPPLEMENTAL_RECORD_UI":"C002916"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Imiclopazin (IMICLOPAZINE) is a small molecule drug in the imiclopazine class, but its target and exact mechanism of action are unknown. It is not FDA-approved for any indications. The commercial status of Imiclopazin is unclear, and it may be patented or off-patent. As a result, there is limited information available on its safety profile, pharmacokinetics, or generic manufacturers. Further research is needed to understand the potential benefits and risks of Imiclopazin.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}